Polyrizon (PLRZ) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.00, -0.10% vs the prior close of $10.01.
- Volume 19.25K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PLRZ ends flat (-0.1%) to $10.00. Closed at $10.00, -0.10% vs the prior close of $10.01. Day range $9.00β$10.00, opened at $10.00.
PLRZ daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β PLRZ ends flat (-0.1%) to $10.00
- Closed at $10.00, -0.10% vs the prior close of $10.01. Day range $9.00β$10.00, opened at $10.00.
- Volume was 19.25K shares, 0.3x its 50-day average of 57.32K β lighter than usual.
- Price is -7.8% vs its 50-day average ($10.85) and -22.0% vs its 200-day average ($12.82).
- 52-week range $2.88β$18.20; today's close sits at 46% of that range, 45.1% below the 52-week high.
Oct 15, 2026 β PLRZ slides 3.8% to $10.01
- Closed at $10.01, -3.84% vs the prior close of $10.41. Day range $9.80β$10.68, opened at $10.31.
- Volume was 73.30K shares, 1.3x its 50-day average of 56.40K.
- Price is -8.0% vs its 50-day average ($10.88) and -21.8% vs its 200-day average ($12.81).
- 52-week range $2.88β$18.20; today's close sits at 47% of that range, 45.0% below the 52-week high.
Oct 14, 2026 β PLRZ jumps 6.9% to $10.41, 4 up days in a row
- Closed at $10.41, +6.88% vs the prior close of $9.74. Day range $9.54β$11.58, opened at $10.09.
- Volume was 90.20K shares, 1.5x its 50-day average of 59.05K.
- Price is -4.5% vs its 50-day average ($10.91) and -18.7% vs its 200-day average ($12.80).
- 52-week range $2.88β$18.20; today's close sits at 49% of that range, 42.8% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 β PLRZ jumps 7.6% to $9.74, 3 up days in a row
- Closed at $9.74, +7.62% vs the prior close of $9.05. Day range $8.00β$10.00, opened at $9.16.
- Volume was 47.00K shares, 0.8x its 50-day average of 60.02K.
- Price is -10.6% vs its 50-day average ($10.90) and -23.8% vs its 200-day average ($12.79).
- 52-week range $2.88β$18.20; today's close sits at 45% of that range, 46.5% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 β PLRZ rises 0.7% to $9.05
- Closed at $9.05, +0.69% vs the prior close of $8.99. Day range $8.76β$9.14, opened at $9.05.
- Volume was 6.40K shares, 0.1x its 50-day average of 61.83K β lighter than usual.
- Price is -17.1% vs its 50-day average ($10.92) and -29.2% vs its 200-day average ($12.78).
- 52-week range $2.88β$18.20; today's close sits at 40% of that range, 50.3% below the 52-week high.
Oct 9, 2026 β PLRZ rises 1.3% to $8.99
- Closed at $8.99, +1.33% vs the prior close of $8.87. Day range $8.22β$9.51, opened at $8.67.
- Volume was 40.10K shares, 0.7x its 50-day average of 61.57K.
- Price is -18.0% vs its 50-day average ($10.96) and -29.6% vs its 200-day average ($12.77).
- 52-week range $2.88β$18.20; today's close sits at 40% of that range, 50.6% below the 52-week high.
Oct 8, 2026 β PLRZ slides 3.1% to $8.87, a 6-month low
- Closed at $8.87, -3.06% vs the prior close of $9.15. Day range $8.70β$9.31, opened at $9.31.
- Volume was 10.30K shares, 0.2x its 50-day average of 62.41K β lighter than usual.
- Price is -19.5% vs its 50-day average ($11.01) and -30.5% vs its 200-day average ($12.76).
- 52-week range $2.88β$18.20; today's close sits at 39% of that range, 51.3% below the 52-week high.
Oct 7, 2026 β PLRZ slides 5.4% to $9.15, a 6-month low
- Closed at $9.15, -5.38% vs the prior close of $9.67. Day range $9.00β$9.27, opened at $9.27.
- Volume was 5.10K shares, 0.1x its 50-day average of 64.08K β lighter than usual.
- Price is -17.4% vs its 50-day average ($11.07) and -28.3% vs its 200-day average ($12.76).
- 52-week range $2.88β$18.20; today's close sits at 41% of that range, 49.7% below the 52-week high.
Oct 6, 2026 β PLRZ jumps 4.4% to $9.67
- Closed at $9.67, +4.43% vs the prior close of $9.26. Day range $9.26β$9.67, opened at $9.50.
- Volume was 6.20K shares, 0.1x its 50-day average of 66.36K β lighter than usual.
- Price is -13.0% vs its 50-day average ($11.11) and -24.3% vs its 200-day average ($12.77).
- 52-week range $2.88β$18.20; today's close sits at 44% of that range, 46.9% below the 52-week high.
Oct 5, 2026 β PLRZ slides 3.6% to $9.26, a 6-month low, 3 down days in a row
- Closed at $9.26, -3.64% vs the prior close of $9.61. Day range $9.13β$9.88, opened at $9.48.
- Volume was 17.00K shares, 0.2x its 50-day average of 68.43K β lighter than usual.
- Price is -17.3% vs its 50-day average ($11.20) and -27.5% vs its 200-day average ($12.77).
- 52-week range $2.88β$18.20; today's close sits at 42% of that range, 49.1% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 2, 2026 β PLRZ slides 6.9% to $9.61, a 6-month low
- Closed at $9.61, -6.88% vs the prior close of $10.32. Day range $9.15β$10.87, opened at $10.56.
- Volume was 56.50K shares, 0.8x its 50-day average of 69.16K.
- Price is -15.0% vs its 50-day average ($11.31) and -24.8% vs its 200-day average ($12.78).
- 52-week range $2.88β$18.20; today's close sits at 44% of that range, 47.2% below the 52-week high.
PLRZ latest news & SEC filings
Every SEC filing by or about PLRZ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Oct 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 1, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Sep 28, 2026 Β· Form F-1/A β F-1/A filing
F-1/A filing
Sep 28, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 18, 2026 Β· Form F-1 β F-1 filing
F-1 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 4, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 4, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 4, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 29, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade PLRZ
- How much it moves: over the last 20 sessions the average daily move was 3.61% (largest 7.6%). That is a volatile stock.
- Liquidity: about 23.79K shares (β$237.93K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.00 vs a range of $2.88β$18.20 (46% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:6 on Nov 28, 2025, 1:250 on May 27, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 24 sales; latest: Liron Carmel sold 942 shares on Mar 31, 2026.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 28, 2026; 6-K Sep 4, 2026.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
PLRZ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.00 | 10.00 | 9.00 | 10.00 | 19.25K |
| Oct 15, 2026 | 10.31 | 10.68 | 9.80 | 10.01 | 73.30K |
| Oct 14, 2026 | 10.09 | 11.58 | 9.54 | 10.41 | 90.20K |
| Oct 13, 2026 | 9.16 | 10.00 | 8.00 | 9.74 | 47.00K |
| Oct 12, 2026 | 9.05 | 9.14 | 8.76 | 9.05 | 6.40K |
| Oct 9, 2026 | 8.67 | 9.51 | 8.22 | 8.99 | 40.10K |
| Oct 8, 2026 | 9.31 | 9.31 | 8.70 | 8.87 | 10.30K |
| Oct 7, 2026 | 9.27 | 9.27 | 9.00 | 9.15 | 5.10K |
| Oct 6, 2026 | 9.50 | 9.67 | 9.26 | 9.67 | 6.20K |
| Oct 5, 2026 | 9.48 | 9.88 | 9.13 | 9.26 | 17.00K |
| Oct 2, 2026 | 10.56 | 10.87 | 9.15 | 9.61 | 56.50K |
| Oct 1, 2026 | 10.30 | 10.48 | 10.16 | 10.32 | 2.00K |
| Sep 30, 2026 | 10.39 | 10.87 | 10.08 | 10.78 | 13.50K |
| Sep 29, 2026 | 10.61 | 11.00 | 10.36 | 10.49 | 8.70K |
| Sep 28, 2026 | 10.50 | 10.76 | 10.36 | 10.36 | 4.50K |
| Sep 25, 2026 | 10.50 | 10.77 | 10.50 | 10.77 | 1.00K |
| Sep 24, 2026 | 10.93 | 11.35 | 10.50 | 10.51 | 13.40K |
| Sep 23, 2026 | 10.62 | 11.99 | 10.09 | 11.16 | 40.10K |
| Sep 22, 2026 | 11.03 | 11.03 | 10.50 | 10.66 | 6.50K |
| Sep 21, 2026 | 11.00 | 11.00 | 10.55 | 10.90 | 14.80K |
About Polyrizon
Polyrizon (PLRZ) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in RA'ANANA. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1893645.
PLRZ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Oz Adler | Director | Apr 1, 2026 |
| Liron Carmel | Director | Apr 1, 2026 |
| Asaf Itzhaik | Director | Mar 18, 2026 |
| Tomer Izraeli | Chief Executive Officer | Apr 1, 2026 |
| Liat Sidi | Director | Mar 18, 2026 |
| Tidhar Turgeman | Chief Technology Officer | Mar 31, 2026 |
| Yehonatan Zalman Vinokur | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nir Benyosef | Chief Financial Officer | Mar 18, 2026 |
| Tomer Izraeli | Chief Executive Officer | Apr 1, 2026 |
| Eyal S Ron | Chief Science Officer | Mar 18, 2026 |
| Tidhar Turgeman | Chief Technology Officer | Mar 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 31, 2026 | Liron Carmel | Sale | 942 | $12.36 |
| Mar 31, 2026 | Liron Carmel | Sale | 942 | $12.36 |
| Mar 31, 2026 | Liron Carmel | Sale | 942 | $12.36 |
| Mar 31, 2026 | Liron Carmel | Sale | 942 | $12.36 |
| Mar 31, 2026 | Oz Adler | Sale | 3,292 | $12.05 |
| Mar 31, 2026 | Oz Adler | Sale | 3,292 | $12.05 |
| Mar 31, 2026 | Oz Adler | Sale | 3,292 | $12.05 |
| Mar 31, 2026 | Oz Adler | Sale | 3,292 | $12.05 |
| Mar 31, 2026 | Tomer Izraeli | Sale | 500 | $11.85 |
| Mar 31, 2026 | Tomer Izraeli | Sale | 500 | $11.85 |
| Mar 31, 2026 | Tomer Izraeli | Sale | 500 | $11.85 |
| Mar 31, 2026 | Tomer Izraeli | Sale | 500 | $11.85 |
| Mar 30, 2026 | Liron Carmel | Sale | 100 | $11.00 |
| Mar 30, 2026 | Liron Carmel | Sale | 100 | $11.00 |
| Mar 30, 2026 | Liron Carmel | Sale | 100 | $11.00 |
PLRZ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
PLRZ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PLRZ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.